Answers are grounded in this paper and cite their sources.
Chronic venous disease is characterized by sustained venous hypertension, endothelial dysfunction, inflammation, microvascular alterations, edema, and progressive tissue remodeling, providing a rationale for locally acting therapeutic strategies. Venoactive natural compounds, including escin, flavonoids, anthocyanins, and proanthocyanidins, possess pharmacologically relevant vascular, antioxidant, and anti-inflammatory activities, but their pharmaceutical application is frequently constrained by poor aqueous solubility, chemical instability, unfavorable skin partitioning, and limited permeation. This review examines deep eutectic solvents (DESs) and natural deep eutectic solvents (NADESs) as multifunctional platforms connecting phytochemical extraction with primarily local dermal delivery and, where systemic absorption is intended, transdermal delivery. Particular emphasis is placed on the relationships between hydrogen-bond acceptor/donor composition, molar ratio, water content, polarity, viscosity, and solvation behavior and three interconnected functions: enhanced extraction and solubilization, stabilization of labile phytochemicals, and modulation of cutaneous transport. DESs/NADESs may enhance skin delivery through composition-dependent interactions with stratum-corneum lipids and keratin, hydration of the barrier, and modification in drug thermodynamic activity and vehicle–skin partitioning. These mechanisms are particularly relevant to flavonoids, for which hydroxylation, glycosylation, molecular size, and hydrophilic–lipophilic balance strongly influence skin penetration and retention. Emerging DES-based microemulsions, films, hydrogels, and related systems demonstrate promising improvements in solubility, stability, and skin delivery. However, direct evidence in venous disorders remains limited, and translation requires composition-specific safety assessment, human-skin permeation and retention studies, standardized characterization of multicomponent extracts, and clinically relevant efficacy studies. Overall, DESs/NADESs may link phytochemical extraction with dermal formulation, but their clinical value for venous disorders remains to be established.
No takes yet. Share an insight, caveat, or question.
Suručić et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: